(Q43734545)

26 November 2017

Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study (English)

1 reference

26 November 2017

1 reference

Reinisch W

1

1 reference

26 November 2017

Nahavandi H

2

1 reference

26 November 2017

Santella R

3

1 reference

26 November 2017

Zhang Y

4

1 reference

26 November 2017

Gasché C

5

1 reference

26 November 2017

Moser G

6

1 reference

26 November 2017

Waldhör T

7

1 reference

26 November 2017

Gangl A

8

1 reference

26 November 2017

Vogelsang H

9

1 reference

26 November 2017

Knobler R

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Alimentary Pharmacology & Therapeutics

26 November 2017

1 reference

26 November 2017

15

1 reference

26 November 2017

9

1 reference

26 November 2017

1313-1322

1 reference

T cells in inflammatory bowel disease: protective and pathogenic roles.

26 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01054.X

10.1046/J.1365-2036.2001.01054.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference